Response to: "a somatization comorbidity phenotype impacts response to therapy in rheumatoid arthritis: Post hoc results from the certolizumab pegol phase 4 PREDICT trial"

Annelise Madison; Barbara L. Andersen; Ali Ajam

doi:10.1186/s13075-019-1848-4

Response to: "a somatization comorbidity phenotype impacts response to therapy in rheumatoid arthritis: Post hoc results from the certolizumab pegol phase 4 PREDICT trial"

Annelise Madison, Barbara L. Andersen, Ali Ajam

Research output: Contribution to journal › Letter › peer-review

Original language	English
Article number	65
Journal	Arthritis Research and Therapy
Volume	21
Issue number	1
DOIs	https://doi.org/10.1186/s13075-019-1848-4
State	Published - Feb 20 2019

Access to Document

10.1186/s13075-019-1848-4

Cite this

@article{912ecfcbbca94a5b8b0ca1e41481e440,

title = "Response to: {"}a somatization comorbidity phenotype impacts response to therapy in rheumatoid arthritis: Post hoc results from the certolizumab pegol phase 4 PREDICT trial{"}",

author = "Annelise Madison and Andersen, \{Barbara L.\} and Ali Ajam",

year = "2019",

month = feb,

day = "20",

doi = "10.1186/s13075-019-1848-4",

language = "English",

volume = "21",

journal = "Arthritis Research and Therapy",

issn = "1478-6354",

number = "1",

}

TY - JOUR

T1 - Response to

T2 - "a somatization comorbidity phenotype impacts response to therapy in rheumatoid arthritis: Post hoc results from the certolizumab pegol phase 4 PREDICT trial"

AU - Madison, Annelise

AU - Andersen, Barbara L.

AU - Ajam, Ali

PY - 2019/2/20

Y1 - 2019/2/20

UR - http://www.scopus.com/inward/record.url?scp=85061997225&partnerID=8YFLogxK

U2 - 10.1186/s13075-019-1848-4

DO - 10.1186/s13075-019-1848-4

M3 - Letter

C2 - 30786929

AN - SCOPUS:85061997225

SN - 1478-6354

VL - 21

JO - Arthritis Research and Therapy

JF - Arthritis Research and Therapy

IS - 1

M1 - 65

ER -

Response to: "a somatization comorbidity phenotype impacts response to therapy in rheumatoid arthritis: Post hoc results from the certolizumab pegol phase 4 PREDICT trial"

Access to Document

Other files and links

Cite this